Letter to the Editor | Published:

Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults

Leukemia volume 30, pages 11771180 (2016) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , , , . Adolescent and young adult (AYA) oncology in the United States: a specialty in its late adolescence. J Pediatr Hematol Oncol 2015; 37: 161–169.

  2. 2.

    , , , , , et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group. Cancer 2013; 119: 4162–4169.

  3. 3.

    , , , , , et al. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials. Cancer 2013; 119: 4170–4179.

  4. 4.

    National Cancer Data Base. Available from (accessed date 24 March 2015).

  5. 5.

    , , . The estimation of average hazard ratios by weighted Cox regression. Stat Med 2009; 28: 2473–2489.

  6. 6.

    , , , . Significance levels from repeated P-values with multiply-imputed data. Stat Sinica 1991; 1: 65–92.

  7. 7.

    , . Multiple imputation for interval estimation from simple random samples with ignorable nonresponse. J Am Stat Assoc 1986; 81: 366–374.

  8. 8.

    , , , , , et al. Patterns of care and survival for adolescents and young adults with acute leukaemia—a population-based study. Br J Cancer 1999; 79: 658–665.

  9. 9.

    , , , , , et al. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk Res 2013; 37: 1004–1009.

  10. 10.

    , . Getting to the heart of improving outcomes for patients with acute promyelocytic leukemia. Oncology 2012; 26: 647–649.

  11. 11.

    , , , , , et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96: 1247–1253.

  12. 12.

    All-trans retinoic acid (systemic tretinoin): Drug Information. Available from (accessed date 26 June 2015).

Download references

Acknowledgements

This study was funded by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and the Division of Hematology. RSG is a Kern Health Care Delivery Scholar.

Author information

Affiliations

  1. Division of Hematology, Mayo Clinic, Rochester, MN, USA

    • R S Go
    •  & A Al-Kali
  2. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA

    • R S Go
    • , N D Shah
    •  & E B Habermann
  3. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA

    • A C Bartley

Authors

  1. Search for R S Go in:

  2. Search for A C Bartley in:

  3. Search for A Al-Kali in:

  4. Search for N D Shah in:

  5. Search for E B Habermann in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to R S Go.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/leu.2015.239

Further reading